Nanox (NASDAQ: NNOX) has signed a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The deal, announced on September 11, 2026, represents Nanox's third Latin American market this year, following Argentina and Peru, signaling the company's accelerating efforts to penetrate emerging markets and drive broader adoption of its affordable imaging technology.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship could facilitate entry into the public healthcare system, potentially leading to widespread deployment of the Nanox.ARC across Costa Rica's hospitals and clinics. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and adaptation to local requirements, which is critical for gaining acceptance among healthcare providers and regulators.
The agreement matters because it underscores Nanox's strategic focus on expanding into Latin America, where access to advanced medical imaging is often limited due to cost and infrastructure constraints. By partnering with a local distributor that already supplies the CCSS, Nanox gains a direct channel to a key public payer, potentially accelerating adoption and demonstrating the viability of its technology in resource-constrained settings. The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. Its introduction in Costa Rica could enhance early detection of diseases, improve clinical efficiency, and support preventive care, aligning with Nanox's vision to drive the world's transition to preventive health care.
Nanox's ecosystem includes Nanox.ARC, Nanox.AI (AI-based algorithms for CT interpretation), Nanox.CLOUD (cloud-based data management and analytics), Nanox.MARKETPLACE and USARAD Holdings (remote radiology and teleradiology services), and Nanox Health IT (RIS, PACS, AI, dictation, and secure infrastructure solutions). This integrated platform aims to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The Costa Rica deal not only expands Nanox's footprint but also validates its model of combining affordable hardware with AI and cloud services to address unmet needs in underserved markets.
For investors, the announcement signals progress in Nanox's commercialization strategy and could bolster confidence in its ability to generate revenue from new geographies. However, the company faces risks, including regulatory hurdles, competition, and the challenge of scaling operations in diverse markets. As noted in its forward-looking statements, various factors beyond management's control could cause actual results to differ materially. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. To view the full press release, visit https://ibn.fm/C77lJ.
Overall, the Costa Rica distribution agreement represents a significant step in Nanox's mission to democratize medical imaging. By leveraging local partnerships and a phased regulatory approach, Nanox is positioning itself to capture growth in Latin America and beyond. The success of this venture could serve as a blueprint for further expansions, reinforcing the company's potential to transform healthcare delivery in emerging economies.
